According to a new report, published by KBV research, The Global Bone & Joint Health Supplements Market size is expected to reach $19.3 billion by 2028, rising at a market growth of 9.0% CAGR during the forecast period.
The Pregnant woman segment is showcasing a CAGR of 9.3% during (2022 - 2028). It is because the baby developing inside the mother's womb needs a lot of calcium to form a strong skeleton. The latter three months of pregnancy are when this demand is most pressing. The baby would suck calcium from the mother's bones if she doesn't get enough of it. Women who are pregnant have stronger calcium absorption than women who are just not.
The Tablets segment acquired maximum revenue share in the Global Bone & Joint Health Supplements Market by Form in 2021 thereby, achieving a market value of $7.1 billion by 2028. Due to the simple availability of varied dosage patterns, simple packaging, storage, and cost-effectiveness, the tablet form of bone and joint health supplements is frequently used. Tablet-based supplements for bone and joint health are ingested because they contain a variety of nutrients, including vitamins and omega-3 fatty acids.
The Calcium segment has shown growth rate of 9.2% during (2022 - 2028). Because dairy products are a key source of calcium, people who are lactose intolerant are particularly affected by calcium deficiencies. According to experts' estimates cited by the National Institute of Diabetes and Digestive & Kidney Diseases, lactose malabsorption affects roughly 68 percent of the population. Some regions of the world experience lactose malabsorption more frequently than others.
The Supermarkets/hypermarkets segment is leading the Global Bone & Joint Health Supplements Market by Distribution Channel in 2021 thereby, achieving a market value of $8.1 billion by 2028. Supermarkets are a tiny but well-established sales channel for the health food sector because they decades ago expanded the product lines of traditional local grocers and corner shops to include items like health supplements. It's interesting to note that, unlike pharmacies, most things purchased at supermarkets are bought as gifts or for family members rather than for personal consumption.
The North America market dominated the Global Bone & Joint Health Supplements Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $6.2 billion by 2028.The Europe market is exhibiting a CAGR of 8.3% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 9.7% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/bone-joint-health-supplements-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Procter and Gamble Company, BASF SE, Amway Corporation, Pfizer, Inc., Glanbia PLC, Bayer AG, Archer Daniels Midland Company, Reckitt Benckiser Group PLC, Nutramax Laboratories, Inc., and NOW Foods, Inc.
By Target Consumers
By Form
By Type
By Distribution Channel
By Geography
Companies Profiled
Unique Offerings 
